Exponent's EUR750M Continuation Vehicle for H&MV Engineering: The Valuation Math LPs Should Check

    TL;DR: Exponent closed a roughly EUR750 million ($865 million) single-asset continuation vehicle for H&MV Engineering on August 11, 2026, valuing the Limerick-based high-voltage electrical contractor...

    ByJeff Barnes, MBA
    ·11 min read
    Reviewed by Jeff Barnes — CEO of Angel Investors Network · MBA · $1B+ in Capital Formation
    Exponent's EUR750M Continuation Vehicle for H&MV Engineering: The Valuation Math LPs Should Check
    TL;DR: Exponent closed a roughly EUR750 million ($865 million) single-asset continuation vehicle for H&MV Engineering on August 11, 2026, valuing the Limerick-based high-voltage electrical contractor at EUR1.4 billion ($1.6 billion), according to Alternatives Watch. Apollo S3, Pantheon, and SQ Capital co-led the new vehicle. Before you evaluate any CV allocation like this one, you need to understand who actually set that EUR1.4 billion number and what leverage, if any, the buyer had to push back on it.
    Key Takeaways
    • Exponent, the London and Dublin-based mid-market firm, moved H&MV Engineering out of an existing fund and into a new single-asset vehicle at a EUR1.4 billion valuation, roughly triple the EUR61 million revenue base H&MV had in 2020 and in line with revenue that is expected to hit EUR1 billion in FY26.
    • A single-asset continuation vehicle (CV) concentrates new investor capital in one company. There is no diversification cushion if H&MV misses its five-year target of EUR3 billion in revenue.
    • The price was set through a process where Exponent, the seller, also controls the buyer-side entity. A fairness opinion from an independent valuation firm is the standard check on that conflict, but it is not the only check LPs should demand.
    • Existing limited partners in Exponent's earlier fund get a binary choice: roll their stake into the new vehicle at the new valuation, or cash out now. Neither option is risk-free, and the choice reveals a lot about how confident insiders are in the new price.

    What Exponent Actually Closed

    H&MV Engineering designs, builds, and commissions high-voltage electrical infrastructure: substations, grid connections, and the switching equipment that lets data centers, wind farms, and battery storage sites draw power off the grid. The company is headquartered in Castletroy, Limerick, and has grown from roughly 300 employees in 2020 to more than 1,900 today. Revenue over that period went from EUR61 million to an expected EUR1 billion in fiscal 2026, according to the company's announcement carried on PR Newswire. That is sixteen-fold revenue growth in six years, riding the data center buildout and the grid upgrades renewable power requires.

    Exponent has been H&MV's private equity backer since 2021. Rather than sell the company outright or hold it inside its existing fund past that fund's natural life, Exponent structured a continuation vehicle: a new fund created to buy one asset, or a small handful of assets, out of an older fund. The GP running the old fund also runs the new one. Here, H&MV is the sole asset. That is what "single-asset CV" means, and it is the most aggressive form of the structure because there is nothing to diversify the risk sitting alongside H&MV.

    Apollo's S3 platform, Pantheon, and SQ Capital co-led the new investor group, according to the Irish Examiner. The round was oversubscribed, according to Dealroom's reporting, and the fresh capital is earmarked for H&MV's US expansion, where the company already operates through its Cooke Power Services subsidiary. CEO PJ Flanagan said the deal "gives H&MV the long-term backing to scale at the pace of the markets we serve." Completion was expected in September 2026.

    How Continuation Vehicle Pricing Actually Gets Set

    Here is the mechanic every accredited investor needs to internalize before writing a check into a CV. The general partner sits on both sides of the trade. Exponent is the seller, because it manages the existing fund that has held H&MV since 2021. Exponent is also, functionally, the party structuring the buyer, since it is the sponsor negotiating with Apollo S3, Pantheon, and SQ Capital over the price they will pay to get in. One firm, one deal team, both chairs at the table.

    That conflict does not disqualify the transaction. It is why the structure exists: GPs want to hold onto winning assets longer than a traditional ten-year fund life allows, and CVs let them do that while giving existing investors a way out. But the conflict is real, and the industry's answer to it is the fairness opinion. A fairness opinion is a written assessment, usually from an investment bank or specialist valuation firm such as Houlihan Lokey or Kroll, stating whether the price paid for the asset falls within a reasonable range from a financial point of view. It is not a certification that the price is optimal. It is a floor, not a ceiling.

    A 2026 analysis from Mayer Brown lays out why that floor matters more now than it used to. The SEC's Private Fund Adviser Rules, which would have made fairness opinions mandatory, were vacated by the Fifth Circuit in June 2024. The core anti-fraud and fiduciary duty provisions of the Investment Advisers Act still apply, but the bright-line procedural requirements are gone. GPs now operate under a "principles-based standard," a polite way of saying there is less of a rulebook and more reliance on each firm's own discipline. The Institutional Limited Partners Association, the trade body representing LPs, closed a public comment period on updated CV guidance on August 5, 2026, days before this deal was announced. The industry is actively rewriting the rules for this kind of transaction while this transaction happens.

    What should genuinely reassure a prospective new investor is competitive tension in the pricing process, not just a single fairness opinion. When multiple institutional buyers such as Apollo S3, Pantheon, and SQ Capital bid against each other for a stake, the resulting price reflects real market demand rather than one appraiser's judgment call. A syndicate of three sophisticated secondaries specialists competing for allocation is a meaningfully different signal than a single buyer accepting whatever price the GP proposes. That is a point in the deal's favor. It does not eliminate the need to ask how the price was actually negotiated.

    The Roll-or-Cash-Out Choice, and Why It Matters

    Every LP in Exponent's fund that has held H&MV since 2021 now faces a decision: roll the existing stake forward into the new vehicle at the EUR1.4 billion valuation, or take cash and exit now. This "status quo" option, the ability to stay invested on roughly the same terms without being forced to sell, is one of the specific protections the Institutional Limited Partners Association has pushed GPs to guarantee since its original 2023 guidance.

    The choice matters as a signal. If a large share of existing LPs roll rather than cash out, that tells you insiders with the deepest knowledge of H&MV's order book and margins think EUR1.4 billion is fair or low. If most take the cash, that is worth asking about. Research published in the Journal of International Financial Markets, Institutions and Money and summarized by RePEc models this exact incentive: GPs have reason to inflate CV valuations to lock in fees and carried interest, and that incentive weakens when a higher share of existing LPs roll forward. Ask Exponent for the rollover rate. It costs the GP nothing to disclose and tells you a great deal.

    Why Single-Asset Concentration Is the Real Risk Here

    A traditional private equity fund holds fifteen to twenty-five companies. If one underperforms, the others cushion the blow. A single-asset CV removes that cushion. New money going into this vehicle is a concentrated bet on one company in one sector executing one growth plan.

    H&MV's growth plan is specific and ambitious: EUR3 billion in revenue within five years, up from an expected EUR1 billion in FY26, and a workforce scaling to 3,000 from roughly 1,900 today, according to the company's own release. The bull case rests on a EUR2 billion order book and a EUR16 billion sales pipeline, plus continued build-out of data centers and grid infrastructure across Europe and the US. High-voltage switching and substation work is a genuine bottleneck in the data center and renewables buildout, and specialist engineering firms with a track record are scarce.

    The bear case is just as specific. A EUR16 billion pipeline is not EUR16 billion of signed contracts, it is management's own estimate of addressable opportunity, and conversion rates vary widely. Data center capex cycles can slow if AI infrastructure spending cools or financing costs rise. H&MV's US expansion, the stated priority for this new capital, means competing against larger, better-capitalized incumbents in an unfamiliar market. Because this is a single company, nothing offsets a miss. If growth flattens even modestly, the EUR1.4 billion valuation has no cushion from other portfolio companies quietly doing fine elsewhere.

    Is a EUR1.4 Billion Valuation for H&MV Actually Reasonable?

    Nobody outside the deal room has H&MV's audited FY26 financials, so an outside observer cannot independently verify the multiple. What can be triangulated: if FY26 revenue lands at roughly EUR1 billion as guided, a EUR1.4 billion enterprise value implies a revenue multiple of about 1.4 times. That is not extreme on its face for a specialist engineering and construction firm, but these businesses typically trade on EBITDA, not revenue, and margins run thinner than in software. The number that actually matters, and the one this article cannot verify from public sources, is H&MV's EBITDA margin and the EBITDA multiple implied by the EUR1.4 billion price. Ask for it before you commit capital. If Exponent will not share the EBITDA figure behind the valuation, that alone is reason to walk away.

    Context helps too. Exponent's flagship fund, Exponent Private Equity Partners V, closed in mid-2025 at more than EUR1 billion in commitments, according to Bloomberg, roughly 20% above target, and the firm has raised approximately EUR4.5 billion across five funds since 2004. A firm of that scale has less desperate need to overprice a CV just to generate liquidity. That is a mild point in the deal's favor, not proof of a fair price. Firms with strong track records still price aggressively when a trophy asset is on the table.

    What to Ask Before You Put Money Into Any Continuation Vehicle

    If you are an accredited investor being pitched an allocation into this CV, or any single-asset continuation vehicle, here is the diligence checklist that actually separates a well-governed deal from a rushed one.

    • Who wrote the fairness opinion, and what is their relationship with the GP? A fairness opinion from a firm with an ongoing commercial relationship with the seller carries less weight.
    • What was the scope of the fairness opinion? Did it cover only the headline transfer price, or also management fee terms, carried interest crystallization, and any side letters given to specific investors?
    • What is the existing LP rollover rate? If Exponent will not disclose what share of existing fund investors elected to roll versus cash out, treat that as a red flag.
    • What EBITDA and margin figures underlie the EUR1.4 billion valuation? Revenue multiples alone tell you little about a construction and engineering services business.
    • Was there genuine competitive bidding, or did the syndicate simply agree to a price Exponent set unilaterally? A three-firm syndicate is a good sign only if its members actually competed on price and terms.
    • What is your liquidity horizon inside the vehicle? CVs typically run three to five years before the next exit event. Confirm you are comfortable being illiquid in a single asset that long.
    • Did any Limited Partner Advisory Committee member also bid as a buyer? ILPA's 2026 draft guidance flags this specific conflict, where an LPAC member's own secondaries arm bids on the asset the LPAC is supposed to independently evaluate.

    None of these questions are exotic. They are the same questions institutional secondaries buyers ask as routine diligence. An accredited investor evaluating a CV allocation through a feeder fund or platform deserves the same answers.

    The Bottom Line for LPs Weighing This Deal

    H&MV Engineering is a real, fast-growing business sitting at the intersection of two durable trends: data center construction and grid modernization for renewables. That is a genuinely attractive place to have capital exposure. The EUR750 million vehicle Exponent closed gives existing investors a clean exit-or-roll choice and brings in three credible co-leads in Apollo S3, Pantheon, and SQ Capital, whose diligence teams presumably kicked the tires on this valuation already.

    None of that substitutes for your own work on how EUR1.4 billion got set as the number, who else was in the room when it was negotiated, and how much capital you want concentrated in one engineering contractor's five-year growth plan. Single-asset CVs reward investors who ask sharp, specific questions before they commit, and they punish investors who assume a big name and an oversubscribed round means the price was automatically fair.

    Frequently Asked Questions

    What is a single-asset continuation vehicle?

    A single-asset continuation vehicle, or CV, is a new private fund created by a private equity firm to hold exactly one company it already owns through an older fund. The GP moves the asset into the new fund at a negotiated price. Existing investors can roll their stake into the new vehicle or take cash, and new investors buy in at the fresh valuation. Exponent's EUR750 million vehicle for H&MV Engineering is a single-asset CV because H&MV is the only company inside it.

    What is a fairness opinion and why does it matter in this deal?

    A fairness opinion is a written assessment from an independent financial firm, such as Houlihan Lokey or Kroll, on whether the price paid in a transaction is fair to sellers from a financial point of view. It matters here because the GP sits on both the buy side and sell side of the deal, a structural conflict of interest. The opinion checks that conflict, though it typically addresses only the headline price, not every term of the transaction.

    Why do existing investors get a roll-or-cash-out choice?

    Institutional Limited Partners Association guidance calls for a "status quo" option so existing LPs are not forced into a transaction they did not choose. Investors who believe the new valuation is fair or low can roll forward into the continuation vehicle. Investors who want liquidity now can cash out at the negotiated price instead.

    What is the main risk of putting new money into a single-asset CV like this one?

    Concentration. Unlike a diversified fund holding fifteen or more companies, a single-asset CV ties your capital entirely to one company's performance. If H&MV's plan to reach EUR3 billion in revenue within five years falls short, there is no other holding to offset the loss, and your capital is typically locked up for three to five years before the next liquidity event.

    Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    J

    About the Author

    Jeff Barnes, MBA